Lexaria Bioscience Corp (LEXX) is a Healthcare · Biotechnology company listed on NASDAQ. Price $3.24 (-1.52%), Market cap $0.02B, 52-week low–high $0.53 ~ $1.53.
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. Its DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodies
Financial statements, price targets, institutional (13F) holdings and related news for Lexaria Bioscience Corp are updated in real time on BlackAll Trade.
Lexaria Bioscience Corp trades at $3.24 (-1.52%). Real-time quotes and charts are available on BlackAll Trade.
Lexaria Bioscience Corp has a market cap of about $0.02B.
Lexaria Bioscience Corp. operates as a biotechnology company. The company offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients